Albatroz Therapeutics is proud to be recognized among Labiotech’s leading biotech companies in Singapore for 2025. This list highlights the most promising life science companies driving advancements in the Singaporean biotech sector.
Inclusion on this list underscores Albatroz’s commitment to developing groundbreaking therapies that address critical unmet needs in the oncology and inflammation fields.